BG
CL icon

Bellevue Group’s Colgate-Palmolive CL Stock Holding History

Bellevue Group’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,100
Closed -$405K – 213
2020
Q1 		$405K Hold
6,100
– – 0.01% 180
2019
Q4 		$420K Hold
6,100
– – 0.01% 202
2019
Q3 		$448K Buy
6,100
+1,449
+31% +$105K 0.01% 175
2019
Q2 		$333K Buy
+4,651
New +$330K 0.01% 177

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bellevue Group's CL Position: Q2 2020 in Review

Bellevue Group sold out of Colgate-Palmolive (CL) in Q2 2020, closing a stake of 6,100 shares — an estimated $405K sold.

Bellevue Group first reported a position in CL in Q2 2019 and held it in 4 quarters. The position peaked at $448K in Q3 2019. 1,516 funds tracked by Wall St. Rank hold CL as of Q2 2020.

  • Bellevue Group reported no remaining Colgate-Palmolive position as of Q2 2020 after selling out during the quarter.
  • Bellevue Group sold 6,100 Colgate-Palmolive shares in Q2 2020, an estimated $405K.
  • Bellevue Group first reported a position in Colgate-Palmolive in Q2 2019 and held it in 4 quarters.
  • Bellevue Group's Colgate-Palmolive position peaked at $448K in Q3 2019.
  • 1,516 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2020.

Based on Bellevue Group's 13F filing for Q2 2020, filed 13 Aug 2020.